Articles
Space-Saving Solutions
By Bob Houghton, Head of Marketing & Communications – Europe & Asia, at Multi Packaging Solutions.
Over the past decade, the amount of information required...
Press Releases
Momenta Discontinues Further Accrual of its Phase 2 Trial of Necuparanib
The decision to discontinue enrollment into the study was based on the recommendation from the independent Data Safety Monitoring Board (DSMB) following...
Industry Reports
Momenta Pharmaceuticals Reports Second Quarter 2016 Financial Results
Momenta Pharmaceuticals, Inc reported its financial results for the second quarter ended June 30, 2016.For the second quarter of 2016, the Company reported total...
Production & Manufacturing
Aurobindo breaks ground on New Jersey facility
Aurobindo is starting to build on its pledge to expand operations in New Jersey, literally. The Indian drugmaker this week broke ground on the...
Drug Research
Shortage of estrogen drugs in US worries trans women: ‘It’s my peace of mind’
The two most popular injectables used to transition are disappearing from shelves as one awaits re-approval by the FDA, but other factors remain murky...
Drug Research
Lupin largest drug maker buys 21 generic brands from Shionogi & Co to strengthen presence in Japanese market
Lupin Ltd, India’s third largest drug maker, will buy a portfolio of 21 generic brands from Osaka-based Shionogi & Co. Ltd at the cost...
Drug Research
Pfizer adds to list of drugmakers under lens for deviating from good manufacturing practices
Pfizer is the latest addition to an expanding list of drug makers found deviating from good manufacturing practices in India.In the last week of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read